Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Discontinuation of Anticoagulation in Patients with Intracranial Hemorrhage at High Thromboembolic Risk

  • Jung, Hwan-Su (Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University School of Medicine) ;
  • Jeon, Ik-Chan (Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University School of Medicine) ;
  • Chang, Chul-Hoon (Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University School of Medicine) ;
  • Jung, Young-Jin (Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University School of Medicine)
  • Received : 2013.06.11
  • Accepted : 2014.01.10
  • Published : 2014.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : There was no abundance of data on the use of anticoagulant in patients with previous high risk of thromboembolic conditions under a newly developed intracranial hemorrhage in Korean society. The purpose of this study was to evaluate the safety of discontinuance and suggest the proper time period for discontinuance of anticoagulant among these patients. Methods : We reviewed the medical records of 19 patients who took anticoagulant because of thromboembolic problems and were admitted to our department with newly developed anticoagulation associated intracranial hemorrhage (AAICH), and stopped taking medicine due to concern of rebleeding from January 2008 to December 2012. Analysis of the incidence of thromboembolic complications and proper withdrawal time of anticoagulant was performed using the Kaplan-Meier method. Results : Our patients showed high risk for thromboembolic complication. The $CHA_2DS_2$-VASc score ranged from two to five. Thromboembolic complication occurred in eight (42.1%) out of 19 patients without restarting anticoagulant since the initial hemorrhage. Among them, three patients (37.5%) died from direct thromboembolic complications. Mean time to outbreak of thromboembolic complication was $21.38{\pm}14.89$ days (range, 8-56 days). The probability of thromboembolic complications at 7, 14, and 30 days since cessation of anticoagulation was 0.00, 10.53, and 38.49%, respectively. Conclusion : Short term discontinuance of anticoagulant within seven days in patients with AAICH who are at high embolic risk ($CHA_2DS_2$-VASc score >2) appears to be relatively safe in Korean people. However, prolonged cessation (more than seven days) may result in increased incidence of catastrophic thromboembolic complications.

Keywords

References

  1. Ananthasubramaniam K, Beattie JN, Rosman HS, Jayam V, Borzak S : How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest 119 : 478-484, 2001 https://doi.org/10.1378/chest.119.2.478
  2. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. : Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults : 2007 Update : A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group : The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 116 : e391-e413, 2007 https://doi.org/10.1161/CIRCULATIONAHA.107.183689
  3. Butler AC, Tait RC : Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage : a 2-year follow-up. Br J Haematol 103 : 1064-1066, 1998 https://doi.org/10.1046/j.1365-2141.1998.01078.x
  4. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. : 2012 focused update of the ESC Guidelines for the management of atrial fibrillation : an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33 : 2719-2747, 2012 https://doi.org/10.1093/eurheartj/ehs253
  5. Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, et al. : Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 120 : 700-705, 2007 https://doi.org/10.1016/j.amjmed.2006.07.034
  6. Hacke W : The dilemma of reinstituting anticoagulation for patients with cardioembolic sources and intracranial hemorrhage : how wide is the strait between Skylla and Karybdis? Arch Neurol 57 : 1682-1684, 2000 https://doi.org/10.1001/archneur.57.12.1682
  7. Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K : Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 44 : 438-442; discussion 443, 1995 https://doi.org/10.1016/0090-3019(95)00249-9
  8. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ : Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach : the euro heart survey on atrial fibrillation. Chest 137 : 263-272, 2010 https://doi.org/10.1378/chest.09-1584
  9. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY : The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1 : a nationwide cohort study. Thromb Haemost 107 : 1172-1179, 2012 https://doi.org/10.1160/TH12-03-0175
  10. Tinker JH, Tarhan S : Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations. JAMA 239 : 738-739, 1978 https://doi.org/10.1001/jama.1978.03280350062016
  11. Wijdicks EF, Schievink WI, Brown RD, Mullany CJ : The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 42 : 769-773, 1998 https://doi.org/10.1097/00006123-199804000-00053

Cited by

  1. Clinical Factors and Perioperative Strategies Associated with Outcome in Preinjury Antiplatelet and Anticoagulation Therapy for Patients with Traumatic Brain Injuries vol.58, pp.3, 2015, https://doi.org/10.3340/jkns.2015.58.3.262
  2. Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation vol.10, pp.12, 2014, https://doi.org/10.1371/journal.pone.0145579